Carmona Jose 4
4 · Rubius Therapeutics, Inc. · Filed Dec 2, 2020
Insider Transaction Report
Form 4
Carmona Jose
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-11-30+400,000→ 400,000 totalExercise: $6.27Exp: 2030-11-29→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on October 1, 2021, then in 12 equal quarterly installments thereafter.